Zurn Elkay Water Solutions director Thomas Christopoul reported receiving 2,900 shares of common stock on February 10, 2026 through a restricted stock unit grant. The award vested immediately but will not be paid out until six months after he stops serving as a director.
After this transaction, Christopoul beneficially owns 117,171 shares of Zurn Elkay common stock, held directly.
Zurn Elkay Water Solutions director David C. Longren received 2,900 shares of common stock on a restricted stock unit grant dated February 10, 2026. The grant vested immediately but will not be paid out until six months after he stops serving as a director. Following this award, he beneficially owns 97,610 shares of Zurn Elkay common stock in direct ownership.
Zurn Elkay Water Solutions Chief Information Officer Michael Troutman reported stock transactions related to performance-based awards. On February 6, 2026, he acquired 17,881 shares of common stock at no cost upon vesting of performance stock units covering the period from January 1, 2023 to December 31, 2025, including dividend equivalents.
On February 10, 2026, 5,922 shares were sold at a weighted average price of $51.8 per share to cover tax withholding and related fees from the vesting. After these transactions, Troutman directly owned 62,694 common shares, with an additional 1,890 shares held indirectly through a 401(k) plan.
Zurn Elkay Water Solutions Corp President Jeffrey A. Schoon reported equity changes tied to performance-based awards and related tax obligations. On February 6, 2026, he acquired 24,981 shares of common stock for no cash consideration upon vesting of performance stock units based on a three-year performance period ending December 31, 2025.
On February 10, 2026, he sold 12,034 common shares at a weighted average price of $51.80 to cover tax withholding and related fees from the vesting. Following these transactions, he holds 62,541 common shares directly, plus 2,196 shares indirectly via a trust and 846 shares via a 401(k) plan.
Todd Adams has filed a notice of proposed sale for 5,050 shares of ZWS common stock. The shares are expected to be sold through Fidelity Brokerage Services LLC on the NYSE around 02/10/2026, with an aggregate market value of $261,601.62 and 166,797,974 shares outstanding.
The 5,050 shares were acquired on 02/09/2026 via restricted stock vesting from the issuer as compensation. Over the prior three months, Todd Adams sold 263,347 common shares for gross proceeds of $13,873,804.67, and the notice confirms he knows of no undisclosed material adverse information.
A holder of common stock filed a notice of proposed sale under Rule 144 to sell 35,267 shares through Fidelity Brokerage Services LLC on the NYSE. The filing shows an aggregate market value of $1,829,694.68 for these shares, with 166,797,974 shares outstanding at the issuer level. The shares were acquired on 02/09/2026 via restricted stock vesting as compensation, with the planned sale date listed as 02/10/2026. By signing, the seller represents they are not aware of any material adverse, non‑public information about the issuer’s current or prospective operations.
A holder of ZWS common stock has filed a notice of proposed sale under Rule 144 to sell 5,922 shares through Fidelity Brokerage Services LLC on or about 02/10/2026 on the NYSE, with an aggregate market value of $308,156.13.
The 5,922 common shares were acquired from the issuer on 02/09/2026 through restricted stock vesting as compensation. Shares of common stock outstanding were 166,797,974 at the time referenced, providing context for the relative size of the planned sale.
Zurn Elkay Water Solutions insider plans a stock sale under Rule 144. A person related to the company filed to sell 12,034 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $625,059.09, based on recent prices.
The shares were acquired on 02/09/2026 through restricted stock vesting from the issuer as compensation, in the same 12,034-share amount. The notice states that the filer is not aware of any undisclosed material adverse information about the company’s current or future operations.
A holder of ZWS common stock filed a Form 144 notice to sell 6,097 shares, with an aggregate market value of $317,230.14. The planned sale date is February 10, 2026 on the NYSE through Fidelity Brokerage Services LLC.
The shares come from restricted stock vesting on February 9, 2026, received from the issuer as compensation. The filing also notes that 166,797,974 shares of the issuer’s common stock are outstanding. The seller represents they are not aware of undisclosed material adverse information about the issuer.
A shareholder of ZWS filed a notice of proposed sale of 7,639 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $397,268.36.
The shares were acquired on 02/09/2026 via restricted stock vesting as compensation from the issuer. Shares outstanding were 166,797,974; this is a baseline figure, not the amount being sold.